先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02096 先声药业

已收盘 12-15 16:08:35

13.040

-0.050

-0.38%

最高13.180	最低12.760	成交量946.70万
今开13.090	昨收13.090	日振幅3.21%
总市值338.52亿	流通市值338.52亿	总股本25.96亿
成交额1.23亿	换手率0.36%	流通股本25.96亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02096","market":"HK","secType":"STK","nameCN":"先声药业","latestPrice":13.04,"timestamp":1765786115005,"preClose":13.09,"halted":0,"volume":9467000,"delay":0,"floatShares":2596000000,"shares":2596000000,"eps":0.3223685208581367,"marketStatus":"已收盘","change":-0.05,"latestTime":"12-15 16:08:35","open":13.09,"high":13.18,"low":12.76,"amount":123352975,"amplitude":0.032086,"askPrice":13.05,"askSize":12000,"bidPrice":13.04,"bidSize":35000,"shortable":3,"etf":0,"ttmEps":0.3954951736115975,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":5,"adr":0,"listingDate":1603728000000,"exchange":"SEHK","adjPreClose":13.09,"dividendRate":0.013405,"openAndCloseTimeList":[[1765762200000,1765771200000],[1765774800000,1765785600000]],"volumeRatio":1.298465,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02096/tweets","defaultTab":"tweets","newsList":[{"id":"2591693127","title":"国金证券：首予先声药业(02096)“买入”评级目标价20.16港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591693127","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591693127?lang=zh_cn&edition=full","pubTime":"2025-12-15 09:09","pubTimestamp":1765760977,"startTime":"0","endTime":"0","summary":"根据DCF估值，对应合理目标价为20.16港币，首次覆盖，给予“买入”评级。凭借自研+BD双轮驱动，商业化创新药已增至10款，创新药收入占比从2020年的45%提升至2025H1的77%，收入结构持续优化，已完成从仿制药龙头向创新药企的战略转型，创新转型成果显著。目前公司加强早研投入，未来数十款早研管线中仍有持续BD可能。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096"],"gpt_icon":0},{"id":"2590558568","title":"每日卖空追踪 | 先声药业 12月10日卖空量成交3.5万股，卖空比例为1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590558568","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590558568?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355427,"startTime":"0","endTime":"0","summary":"先声药业北京时间12月10日，跌0.36%，卖空量成交3.5万股，较上一交易日减少96.12%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163554a43f9f3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163554a43f9f3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","02096"],"gpt_icon":0},{"id":"2590558530","title":"先声药业12月10日遭主力抛售43.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590558530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590558530?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:15","pubTimestamp":1765354552,"startTime":"0","endTime":"0","summary":"12月10日, 先声药业股价跌0.36%，报收13.75元，成交金额3503.7万元，换手率0.10%，振幅2.17%，量比0.35。先声药业今日主力资金净流出43.0万元，上一交易日主力净流出110.2万元。该股近5个交易日上涨4.96%，主力资金累计净流入158.6万元；近20日主力资金累计净流入5533.2万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210162034953535bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210162034953535bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","BK1583","BK1191"],"gpt_icon":0},{"id":"2590398455","title":"创新药概念股盘初强势 歌礼制药-B(01672)涨20.73% 机构指政策鼓励创新药发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2590398455","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590398455?lang=zh_cn&edition=full","pubTime":"2025-12-09 09:38","pubTimestamp":1765244314,"startTime":"0","endTime":"0","summary":"中信证券表示，2025年12月7日，2025创新药高质量发展大会在广州举行，国家医保局现场发布了2025年《国家基本医疗保险、生育保险和工伤保险药品目录》及《商业健康保险创新药品目录》。该机构认为，国家医保谈判成功率创历史新高，商保目录有望成为重要增量，政策鼓励创新药发展。看好相关创新药及制药企业。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971163","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","SG9999004220.SGD","SG9999014674.SGD","02096","01477","IE00BVYPNP33.GBP","BK1593","IE00BVYPNQ40.USD","BK1191","IE00BYV24P56.USD","BK1141","02157","159992","BK1574","01672","02268","SG9999015952.SGD","IE00BMCWC346.EUR","01952","BK1583","IE00BGHQDM52.EUR","00867","BK1515","SG9999015978.USD","LU2488822045.USD","SG9999015945.SGD","SG9999015986.USD","06978"],"gpt_icon":0},{"id":"2589140355","title":"每日卖空追踪 | 先声药业 12月08日卖空量成交26.5万股，卖空比例为3.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589140355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589140355?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182626,"startTime":"0","endTime":"0","summary":"先声药业北京时间12月08日，涨1.63%，卖空量成交26.5万股，较上一交易日减少61.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512081634069796147c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512081634069796147c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02096","BK1191"],"gpt_icon":0},{"id":"2589191355","title":"先声药业12月08日主力净流入433.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2589191355","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589191355?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181706,"startTime":"0","endTime":"0","summary":"12月08日, 先声药业股价涨1.63%，报收13.71元，成交金额9960.8万元，换手率0.28%，振幅3.78%，量比1.13。先声药业今日主力资金净流入433.6万元，上一交易日主力净流出95.6万元。该股近5个交易日下跌2.01%，主力资金累计净流入887.0万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入6354.4万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512081615219530fe1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512081615219530fe1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","02096"],"gpt_icon":0},{"id":"2589809752","title":"先声药业(02096)：恩泽舒®与恩度®纳入新版国家医保药品目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589809752","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589809752?lang=zh_cn&edition=full","pubTime":"2025-12-08 07:09","pubTimestamp":1765148946,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先声药业 发布公告，于2025年12月7日，恩泽舒已被正式纳入由国家医保局及人力资源社会保障部印发的《国家基本医疗保险、工伤保险和生育保险药品目录》，并将自2026年1月1日起生效。此外，恩度 亦顺利完成国家医保药品目录续约。恩泽舒是新一代重组人源化抗血管内皮生长因子单克隆抗体，于2025年6月30日在中国获批上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"先声药业(02096)：恩泽舒®与恩度®纳入新版国家医保药品目录","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096","BK1191","BK1583"],"gpt_icon":0},{"id":"2589551173","title":"医药生物行业：ESMO ASIA与ASH共绘双抗/ADC/CAR-T技术新蓝图 前沿疗法迎来验证期","url":"https://stock-news.laohu8.com/highlight/detail?id=2589551173","media":"中泰证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589551173?lang=zh_cn&edition=full","pubTime":"2025-12-08 00:00","pubTimestamp":1765123200,"startTime":"0","endTime":"0","summary":"本周沪深300 指数上涨1.28%，医药生物下跌0.74%，处于31个一级子行业第21 位。12 月第一周，ESMO Asia 和ASH 会议的数据预热对市场情绪产生了积极影响。在ASH 会议上，体内生成CAR-T 技术展示了其颠覆传统复杂制备流程的潜力；在ESMO Asia 上，针对B7-H3 等靶点的ADC药物也在NSCLC 等实体瘤中显示出积极疗效。针对EGFR 突变，双特异性抗体联合TKI 正在重新定义一线标准。在2025 年的ASH 会议上，体内CAR-T 疗法无疑是备受瞩目的焦点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208150630a72a7eff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208150630a72a7eff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02096","BK1191","BK1515","09939","BK1583","BK1161","01530"],"gpt_icon":0},{"id":"2589180412","title":"两款睡眠障碍新药未进医保及商保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589180412","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589180412?lang=zh_cn&edition=full","pubTime":"2025-12-07 13:34","pubTimestamp":1765085643,"startTime":"0","endTime":"0","summary":"2025年12月7日，在北京举行的创新药高质量发展大会上获悉，卫材的莱博雷生片和海南先声的盐酸达利雷生片均未纳入新版国家医保药品目录及商保创新药目录。这两款治疗睡眠障碍的新药此前已通过相关形式审查，具备参评资格。尽管产品在临床应用上有一定前景，但最终未能进入目录。业内人士指出，这可能与药物经济学评估、价格谈判等因素有关。目前患者使用该类药品仍需自费承担较高费用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251207133517952f203f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251207133517952f203f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","02096"],"gpt_icon":0},{"id":"2589852755","title":"交银国际：中国医药1-8批国采接续规则或温和 短期催化剂充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2589852755","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589852755?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:18","pubTimestamp":1764901122,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，本周恒生医疗保健指数涨0.5%，跑输大市。其中，生物药、处方药及器械板块表现较优于其他板块。本周内资偏向防御，倾向获利了结，主要加仓内生增长稳定的传统及低估创新药厂。而外资则较积极，聚焦创新主线中的龙头及产业链上游，包括创新药及CXO标的。1-8批集采接续采购规则转变为询价模式，交银国际认为此规则下整体降价幅度或有限，对港股处方药厂的影响或小于预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK0028","03329","BK1141","BK1574","BK1587","06996","BK0188","02268","BK0082","BK0185","HK0000165453.HKD","02096","LU2488822045.USD","00013","01530","BK0250","BK1161","BK1147","SG9999014674.SGD","BK1593","BK1588","BK1191","BK0010","600056","BK0175"],"gpt_icon":0},{"id":"2589593038","title":"每日卖空追踪 | 先声药业 12月04日卖空量成交14.5万股，卖空比例为2.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589593038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589593038?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837028,"startTime":"0","endTime":"0","summary":"先声药业北京时间12月04日，涨3.89%，卖空量成交14.5万股，较上一交易日减少68.48%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163349a4cc375f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163349a4cc375f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2588190450","title":"先声药业(02096)与旺山旺水(02630)就氢溴酸氘瑞米德韦新适应症订立许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2588190450","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588190450?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:54","pubTimestamp":1764752083,"startTime":"0","endTime":"0","summary":"金吾财讯 | 先声药业(02096)公告公布，于2025年12月3日，集团与旺山旺水(02630)，就氢溴酸氘瑞米德韦新适应症订立许可协议。据该协议，集团将获得氢溴酸氘瑞米德韦在大中华区，于抗呼吸道合胞病毒（“RSV”）感染以及抗人偏肺病毒（HMPV）感染适应症的独家权益。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/NzVmNzI2NGE4ZDk3NWFhOTZkNGE5Nzk4MDcyMTM1NjM3MTc0MDU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NzVmNzI2NGE4ZDk3NWFhOTZkNGE5Nzk4MDcyMTM1NjM3MTc0MDU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970840","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","02096","BK1191","BK1583"],"gpt_icon":0},{"id":"2588198560","title":"旺山旺水-B(02630)与先声药业(02096)就VV116新适应症订立许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2588198560","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588198560?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:32","pubTimestamp":1764750745,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B 公布，公司与先声药业集团有限公司就VV116新适应症订立许可协议。根据该协议，公司将授予先声药业VV116在大中华区抗呼吸道合胞病毒感染以及抗人偏肺病毒感染适应症的独家许可权益。旺山旺水与先声药业强强联合，发挥各自研发、生产及商业化的优势，加速VV116的临床开发和商业化进程，以期惠及更多患者。临床研究中，VV116总体安全性良好，未发现严重不良事件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377030.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","02096","02630","BK1191"],"gpt_icon":0},{"id":"2588010456","title":"每日卖空追踪 | 先声药业 12月03日卖空量成交18万股，卖空比例为2.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588010456","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588010456?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750624,"startTime":"0","endTime":"0","summary":"先声药业北京时间12月03日，跌2.24%，卖空量成交18万股，较上一交易日减少54.55%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163359a4c9ef78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163359a4c9ef78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","BK1583","BK1191"],"gpt_icon":0},{"id":"2588410010","title":"强生三抗新药首次启动 III 期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2588410010","media":"丁香园 Insight 数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588410010?lang=zh_cn&edition=full","pubTime":"2025-12-03 11:26","pubTimestamp":1764732377,"startTime":"0","endTime":"0","summary":"当地时间 12 月 2 日，强生在 ClinicalTrials 官网登记了一项JNJ-79635322治疗复发或难治性多发性骨髓瘤患者的 III 期研究 Trilogy-4。给药方案如下：来源：ClinicalTrials 官网JNJ-79635322 是强生开发的新一代三抗，靶向 BCMA、GPRC5D 和 CD3。在 2025 年 ASCO 大会上，强生首次披露该药的 I 期人体研究数据。首次缓解的中位时间为 1.2 个月。5 名患者出现剂量限制性毒性，4 名因AE死亡。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203122214a4c97b93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203122214a4c97b93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","BK1191","BK1583"],"gpt_icon":0},{"id":"2588879094","title":"流感高峰期来袭！抗流感概念反复活跃，上市公司密集回应市场关切","url":"https://stock-news.laohu8.com/highlight/detail?id=2588879094","media":"腾讯自选股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588879094?lang=zh_cn&edition=full","pubTime":"2025-12-03 10:22","pubTimestamp":1764728562,"startTime":"0","endTime":"0","summary":"亿帆医药公司人士表示，近期公司独家中药产品、用于治疗普通感冒和流感的复方银花解毒颗粒的销量同比已有一定提升，相关生产线目前处于满负荷生产状态。以岭药业工作人员表示，随着流感高峰期的到来，连花清瘟等产品未来销量预期会有所增长。展望后市，光大证券表示，近期流感疫情上升态势明显，可能引发社会公众和市场关注度的提升，从而带动防治和检测流感产品的需求增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512031013219527d73c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512031013219527d73c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","02196","02607","BK1197"],"gpt_icon":0},{"id":"1196207389","title":"先声药业（02096）更新11月股份变动月报表，股本维持2,595,697,618股稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1196207389","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196207389?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:06","pubTimestamp":1764666389,"startTime":"0","endTime":"0","summary":"先声药业集团有限公司于2025年12月2日发布2025年11月股份变动月报表。公告显示，截至2025年11月30日，公司的普通股总数保持在2,595,697,618股，未有新增发行或回购注销等变动活动。截至2025年11月末，公司股本结构继续维持不变，总股数保持在2,595,697,618股。公司表示将持续遵守香港联合交易所上市规则及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"gpt_icon":0},{"id":"2588603384","title":"先声药业12月02日主力净流出212.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588603384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588603384?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:15","pubTimestamp":1764663339,"startTime":"0","endTime":"0","summary":"12月02日, 先声药业股价跌3.80%，报收13.40元，成交金额9238.0万元，换手率0.26%，振幅3.95%，量比1.13。先声药业今日主力资金净流出212.8万元，上一交易日主力净流入967.2万元。该股近5个交易日下跌2.13%，主力资金累计净流入1420.2万元；近20日主力资金累计净流入5212.2万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202161840a71eb524&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202161840a71eb524&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"1148400421","title":"港股创新药概念股午后持续走低，歌礼制药-B、三生制药跌超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148400421","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148400421?lang=zh_cn&edition=full","pubTime":"2025-12-02 13:12","pubTimestamp":1764652353,"startTime":"0","endTime":"0","summary":"12月2日，港股创新药概念股午后持续走低，$歌礼制药-B(01672)$、$三生制药(01530)$跌超5%，$先声药业(02096)$、$同源康医药-B(02410)$、$康诺亚-B(02162)$跌超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c54c8d8de852bbfb4567c558a904e399","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","02096","02410","BK1515","01672","02162","06978","BK1593","BK1574","01530","HK0000165453.HKD","09939","BK1161","BK1191","01477","BK1583"],"gpt_icon":0},{"id":"2588394065","title":"凌科药业递交赴港IPO申请，核心产品LNK01001的商业化已全权委托先声药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2588394065","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588394065?lang=zh_cn&edition=full","pubTime":"2025-12-02 11:44","pubTimestamp":1764647040,"startTime":"0","endTime":"0","summary":"近日，港交所官网披露，凌科药业（浙江）股份有限公司递表港交所主板，中信证券、建银国际为联席保荐人。招股书信息显示，凌科药业是立足中国、面向全球的领先制药公司，专注开创治疗肿瘤、免疫及炎症疾病的新型药物。公司由资深药物开发专家创立，团队成员在药物探索领域经验丰富。其在推进产品开发管线方面效率卓越，核心产品LNK01001及LNK01004取得重大进展，首个候选产品预计将进入临床前阶段。核心产品LNK01001的商业化已全权委托先声药业，双方约定按比例分摊销售收益，但招股书未披露具体分成比例、销售目标及最低采购量条款。（披露易）(编辑：杨燕 林辰)关键字： 医疗","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202115059978af6e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202115059978af6e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","BK1191","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.simcere.com","stockEarnings":[{"period":"1week","weight":-0.0297},{"period":"1month","weight":0.0038},{"period":"3month","weight":-0.0616},{"period":"6month","weight":0.0801},{"period":"1year","weight":0.8767},{"period":"ytd","weight":0.8743}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0351},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0872},{"period":"1year","weight":0.2736},{"period":"ytd","weight":0.295}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"先声药业集团有限公司是一家从事药品的研发、生产和销售的公司。该公司的主要产品为仿制药，包括用于中枢神经系统疾病的产品必存、用于肿瘤疾病的产品捷百舒和捷佰立、以及用于自身免疫疾病的产品英太青。该公司还从事生产创新药，比如用于肿瘤疾病的恩度。该公司还从事为医疗机构销售的第三方药品提供推广服务。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.107139},{"month":2,"riseRate":0.6,"avgChangeRate":0.07279},{"month":3,"riseRate":0.4,"avgChangeRate":-0.021724},{"month":4,"riseRate":0.6,"avgChangeRate":0.009116},{"month":5,"riseRate":0.8,"avgChangeRate":0.158743},{"month":6,"riseRate":0.6,"avgChangeRate":0.036684},{"month":7,"riseRate":0.2,"avgChangeRate":-0.0521},{"month":8,"riseRate":0.4,"avgChangeRate":-0.05132},{"month":9,"riseRate":0.4,"avgChangeRate":-0.0324},{"month":10,"riseRate":0.8,"avgChangeRate":0.108781},{"month":11,"riseRate":0.666667,"avgChangeRate":0.044275},{"month":12,"riseRate":0.5,"avgChangeRate":0.014237}],"exchange":"SEHK","name":"先声药业","nameEN":"SIMCERE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供先声药业(02096)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"先声药业,02096,先声药业股票,先声药业股票老虎,先声药业股票老虎国际,先声药业行情,先声药业股票行情,先声药业股价,先声药业股市,先声药业股票价格,先声药业股票交易,先声药业股票购买,先声药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供先声药业(02096)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}